Cite
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
MLA
Gaba, Prakriti, et al. “Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.” Journal of the American College of Cardiology (JACC), vol. 79, no. 17, May 2022, pp. 1660–71. EBSCOhost, https://doi.org/10.1016/j.jacc.2022.02.035.
APA
Gaba, P., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Juliano, R. A., Jiao, L., Doyle, R. T., Granowitz, C., Tardif, J.-C., Giugliano, R. P., Martens, F. M. A. C., Gibson, C. M., Ballantyne, C. M., Doyle, R. T., Jr, & REDUCE-IT Investigators. (2022). Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. Journal of the American College of Cardiology (JACC), 79(17), 1660–1671. https://doi.org/10.1016/j.jacc.2022.02.035
Chicago
Gaba, Prakriti, Deepak L. Bhatt, Ph. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, et al. 2022. “Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.” Journal of the American College of Cardiology (JACC) 79 (17): 1660–71. doi:10.1016/j.jacc.2022.02.035.